Behavioural Activation for Comorbid Depression in Non-communicable Disease (BEACON) study
Not Applicable
Completed
- Conditions
- Health Condition 1: E08-E13- Diabetes mellitusHealth Condition 2: I00-I99- Diseases of the circulatory systemHealth Condition 3: J00-J99- Diseases of the respiratory systemHealth Condition 4: F32- Major depressive disorder, singleepisode
- Registration Number
- CTRI/2020/05/025048
- Lead Sponsor
- Dr Arun Kandasamy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 56
Inclusion Criteria
Aged 18 years or over
Diagnosed with cardiovascular disease, chronic respiratory disease or diabetes (type 1 or 2)
Current diagnosis of depression (confirmed with a clinician-administered PHQ-9 score of � 10)48
Willing to participate and able to attend therapy sessions in person or by telephone
Other mental or physical illness comorbidities will not be a reason to exclude unless the patient is judged to be too unwell to participate
Exclusion Criteria
Already receiving psychotherapy for depression. Being on antidepressant medication will not however be a reason to exclude.
Lacking capacity to provide informed consent
Unable to take part in therapy because of cognitive impairment, or severity of mental or physical illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method A refined BA intervention, BEACON, including intervention manual, workbooks and training package, ready for trial intervention <br/ ><br> <br/ ><br>An optimised protocol for evaluation of effectiveness and cost effectiveness of BEACON for depression in NCD in LMIC, including an intervention fidelity framework and protocols for process evaluationTimepoint: Baseline and 3 months <br/ ><br>
- Secondary Outcome Measures
Name Time Method Anxiety (GAD-7) <br/ ><br>Health related quality of life (EQ-5D-5L) <br/ ><br>Physical health, using a measure of quality of life and function S(F-36) <br/ ><br>NCD specific outcomes (HbA1c; Blood Pressure, respiratory quality of life)Timepoint: Baseline and 3 months <br/ ><br>